Takeda Pharmaceutical Company Limited
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
Last updated:
Abstract:
Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.
Status:
Grant
Type:
Utility
Filling date:
21 Jan 2015
Issue date:
10 Aug 2021